Decision Making & Cognitive Aging

While abilities like vocabulary resist aging, other abilities such as memory, decision-making, and reasoning, gradually decline. Here is the latest research on decision-making and cognitive aging.

August 2, 2020
Review
Open Access

Guidelines for balancing priorities in structural heart disease during the COVID-19 pandemic

Cardiovascular Revascularization Medicine : Including Molecular Interventions
Jaffar M KhanRon Waksman
August 6, 2020
Open Access

Cognitive and Affective Theory of Mind in Healthy Aging

Experimental Aging Research
Marit F L RuitenbergWim Notebaert
August 3, 2020

Machine learning-based estimation of cognitive performance using regional brain MRI markers: the Northern Manhattan Study

Brain Imaging and Behavior
Michelle R CauncaTatjana Rundek
August 2, 2020

Association of years to parent's sporadic onset and risk factors with neural integrity and Alzheimer's biomarkers

Neurology
Eider M Arenaza-Urquijo EmALFA study
August 4, 2020
Open Access

Anticholinergic Cognitive Burden as a Predictive Factor for In-hospital Mortality in Older Patients in Korea

Annals of Geriatric Medicine and Research
Jae Hyun LeeSeung Jun Han
August 3, 2020

Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease

International Review of Neurobiology
Michael F AlmeidaStephen T Kinsey
August 4, 2020
Review
Open Access

Exercise, the Gut Microbiome, and Frailty

Annals of Geriatric Medicine and Research
Hyung Eun ShinWook Song
August 3, 2020

APOE and metabolic dysfunction in Alzheimer's disease

International Review of Neurobiology
Lance A Johnson
August 7, 2020
Review

Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials

Antioxidants
Noemí Rueda Revilla, Carmen Martínez-Cué
August 4, 2020

Oral literacy in pediatric otolaryngology surgical consultations amongst parents with high levels of decisional conflict

International Journal of Pediatric Otorhinolaryngology
David FornerPaul Hong
August 1, 2020
Open Access

Rapid Geriatric Assessment Using Mobile App in Primary Care: Prevalence of Geriatric Syndromes and Review of Its Feasibility

Frontiers in Medicine
Reshma Aziz MerchantJohn E Morley
August 5, 2020

Beyond Cognitive Screening: Establishing an Interprofessional Perioperative Brain Health Initiative

Journal of the American Geriatrics Society
Justyne DeckerCarol J Peden
August 4, 2020

Age differences in vulnerability to distraction under arousal

Psychology and Aging
Sara N GallantMara Mather
August 1, 2020
Preprint
Open Access

Multiplexed fractionated proteomics reveals synaptic factors associated with cognitive resilience in Alzheimer's Disease

BioRxiv : the Preprint Server for Biology
Becky Catherine CarlyleS. E. Arnold
August 4, 2020

Distraction by unintentional recognition: Neurocognitive mechanisms and effects of aging

Psychology and Aging
John AllenZara M Bergström
August 5, 2020
Open Access

Trajectories of cognitive and motor function between ages 45 and 90 years: a population-based study

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
Kimberly D van der WillikM Arfan Ikram

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

© 2020 Meta ULC. All rights reserved
/feed-previews/decision-making-cognitive-aging/714719b9-7cdb-45c9-b1d9-b877192653ad